Knisbacher, Binyamin A. http://orcid.org/0000-0002-4962-9956
Lin, Ziao http://orcid.org/0000-0002-8495-6995
Hahn, Cynthia K.
Nadeu, Ferran http://orcid.org/0000-0003-2910-9440
Duran-Ferrer, Martí http://orcid.org/0000-0003-1666-5819
Stevenson, Kristen E.
Tausch, Eugen
Delgado, Julio
Barbera-Mourelle, Alex
Taylor-Weiner, Amaro
Bousquets-Muñoz, Pablo http://orcid.org/0000-0002-2969-008X
Diaz-Navarro, Ander http://orcid.org/0000-0001-6808-4800
Dunford, Andrew
Anand, Shankara
Kretzmer, Helene
Gutierrez-Abril, Jesus
López-Tamargo, Sara
Fernandes, Stacey M.
Sun, Clare http://orcid.org/0000-0001-8498-4729
Sivina, Mariela http://orcid.org/0000-0003-0091-0648
Rassenti, Laura Z.
Schneider, Christof
Li, Shuqiang
Parida, Laxmi
Meissner, Alexander http://orcid.org/0000-0001-8646-7469
Aguet, François http://orcid.org/0000-0001-9414-300X
Burger, Jan A. http://orcid.org/0000-0002-6177-7572
Wiestner, Adrian
Kipps, Thomas J.
Brown, Jennifer R. http://orcid.org/0000-0003-2040-4961
Hallek, Michael
Stewart, Chip
Neuberg, Donna S. http://orcid.org/0000-0003-2566-3145
Martín-Subero, José I. http://orcid.org/0000-0001-8809-5195
Puente, Xose S. http://orcid.org/0000-0001-9525-1483
Stilgenbauer, Stephan
Wu, Catherine J. http://orcid.org/0000-0002-3348-5054
Campo, Elias http://orcid.org/0000-0001-9850-9793
Getz, Gad http://orcid.org/0000-0002-0936-0753
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (CA206978, CA206978, CA206978, CA206978, CA206978, CA206978, CA206978, CA206978, CA206978, CA206978, R50CA251956, CA206978, CA213442, CA206978, CA206978, CA206978, CA206978)
European Molecular Biology Organization (ALTF 14-2018)
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (T32HL116324, Intramural Research Program, Intramural Research Program)
EC | Horizon 2020 Framework Programme (BCLLATLAS/810287, BCLLATLAS/810287, BCLLATLAS/810287, BCLLATLAS/810287)
Deutsche Forschungsgemeinschaft (SFB1074, SFB1074, SFB1074)
Ministerio de Economía y Competitividad (SAF2017-87811-R)
Department of Education of the Basque Government
International Business Machines Corporation
UT | University of Texas MD Anderson Cancer Center (Moon Shot Program in CLL, CA016672)
CLL Global Research Foundation
Article History
Received: 30 April 2021
Accepted: 21 June 2022
First Online: 4 August 2022
Competing interests
: The authors declare the following conflicts related to the CLLmap project: C.J.W. receives research support from Pharmacyclics. E.C. has been a consultant for Illumina. G.G. receives research funds from IBM and Pharmacyclics; and is an inventor on patent applications related to SignatureAnalyzer-GPU. S.S. reports honoraria for consultancy, advisory board membership, speaker honoraria, research grants and travel support from AbbVie, Amgen, AstraZeneca, Celgene, Gilead, GSK, Hoffmann La-Roche, Janssen, Novartis. C.J.W., G.G., B.A.K., Z.L. and C.K.H. are inventors on a patent “Compositions, panels, and methods for characterizing chronic lymphocytic leukemia” (PCT/US21/45144). The following conflicts are unrelated to the CLLmap project: F.N. has received honoraria from Janssen for speaking at educational activities. E.T. declares research support by AbbVie and Roche; Advisory Boards and Speakers Bureau for Janssen, AbbVie and Roche. A.W. received research funding from Pharmacyclics, Acerta, Merck, Verastem, Genmab, Nurix. J.R.B. has served as a consultant for AbbVie, Acerta/AstraZeneca, Beigene, Bristol-Myers Squibb/Juno/Celgene, Catapult, Genentech/Roche, Janssen, MEI Pharma, Morphosys AG, Novartis, Pfizer, Rigel; received research funding from Gilead, Loxo/Lilly, Verastem/SecuraBio, Sun, TG Therapeutics; and served on the data safety monitoring committee for Invectys. J.A.B. received research support from AstraZeneca, BeiGene, Gilead, and Pharmacyclics; travel and speaker honoraria from Janssen. X.S.P. is a cofounder of and holds an equity stake in DREAMgenics. C.J.W. holds equity in BioNTech, Inc.. E.C. has been a consultant for Takeda and NanoString Technologies; has received honoraria from Janssen and Roche for speaking at educational activities; and is an inventor on a Lymphoma and Leukemia Molecular Profiling Project patent “Method for subtyping lymphoma subtypes by means of expression profiling” (PCT/US2014/64161). G.G. is an inventor on patent applications related to MSMuTect, MSMutSig, MSIDetect and POLYSOLVER; and is a founder and consultant of and holds privately held equity in Scorpion Therapeutics. The other authors declare no competing interests.